METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Clinical trials for METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE trials appear
Sign up with your email to follow new studies for METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes combo drug melt liver fat better than insulin alone?
Disease control OngoingThis study compares a combination diabetes drug (iGlarLixi) against insulin alone to see which better reduces liver fat in people with type 2 diabetes and a common fatty liver condition called MASLD. About 36 participants will take one of the two treatments for 12 weeks, and doct…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can a Step-by-Step program help latinos beat fatty liver?
Disease control OngoingThis study looks at whether a 26-week behavioral weight loss program called 'Paso a Paso' is practical for Mexican and Central American adults with fatty liver disease and overweight. Researchers will track attendance, weight loss, liver stiffness, and diet changes in 50 particip…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug shows promise for fatty liver cirrhosis in early trial
Disease control OngoingThis study tests an experimental drug called efinopegdutide in 80 adults with liver scarring (cirrhosis) caused by metabolic dysfunction-associated steatohepatitis (MASH), a type of fatty liver disease. The goal is to see if the drug can reduce liver fat, inflammation, and scarri…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
AI spots silent liver danger in ER scans
Diagnosis ENROLLING_BY_INVITATIONThis study tests a computer system that automatically finds fatty liver disease on emergency room scans and alerts doctors to tell patients and arrange follow-up care. About 4,700 adults with fatty liver seen on an ER scan will take part. The goal is to improve how often this hid…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Northwestern University • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New MRI scan could replace painful liver biopsies for MASH patients
Diagnosis ENROLLING_BY_INVITATIONThis study aims to see if a special MRI scan can accurately detect liver scarring (fibrosis) in people with a liver condition called MASH. Researchers will compare the MRI results with standard tests like ultrasound and blood work in 50 adults. If successful, this could offer a n…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
No needles, no pain: new ultrasound aims to spot fatty liver in kids fast
Diagnosis OngoingThis study checks if a quick ultrasound device called Velacur can accurately detect fatty liver disease (MASLD) in children aged 2 to 20. About 200 kids with suspected liver issues will get the ultrasound, and results will be compared to MRI or liver biopsy. The goal is to find a…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Emory University • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
Can a phone app help people with HIV beat fatty liver disease?
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a mobile app-based nutritional program can help people living with HIV and fatty liver disease lose at least 5% of their body weight in 6 months. Participants are randomly assigned to use the app or receive standard lifestyle advice. The goal is to find a…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Hospital Universitari de Bellvitge • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Massive korean study maps the overlap of heart, kidney, and metabolic diseases
Knowledge-focused ENROLLING_BY_INVITATIONThis study examines health data from about 800,000 Korean adults to see how often conditions like obesity, type 2 diabetes, heart disease, chronic kidney disease, and fatty liver occur together. Researchers will analyze national survey and insurance records from 2013 to 2023. No …
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Simple blood test may spot hidden liver trouble in colitis patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether two blood markers, zonulin and LBP, can help detect liver damage in people with both ulcerative colitis (UC) and fatty liver disease. Researchers will measure these markers and use a special ultrasound to check liver stiffness in 100 adults with UC who…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: University Hospital Dubrava • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Fatty liver linked to Body's own oxalate production in new study
Knowledge-focused OngoingThis study looks at how much oxalate the body naturally makes in people with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), a type of fatty liver. Researchers will collect urine samples from 28 adults after they eat a special low-oxalate diet. The goal is to be…
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Major study aims to spare patients painful liver biopsies
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 1,689 adults with fatty liver disease (MASLD) or MASLD with increased alcohol intake (MetALD) to see if non-invasive tests like MRI and Fibroscan can accurately track disease progression. The goal is to reduce the need for liver biopsies in future research and …
Matched conditions: METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: HRI-MAIL-NIT • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC